Latest Coronary artery disease Stories

Stem Cell Therapy for Heart Disease Experts Launch Educational Resource for Cardiologists with Questions Answered by Dr. Howard Walpole FREEPORT, The Bahamas (PRWEB) March 11, 2013 CEO Matt Feshbach of Okyanos Heart Institute, which brings a new standard of care and better quality of life to patients with chronic coronary artery disease using cardiac stem cell therapy, announces an educational resource center launch for healthcare professionals on The American Journal of Cardiology (AJC)...

-- Three-year clinical results for treating clogged vessels in the heart with Absorb presented at American College of Cardiology 2013 SAN FRANCISCO, March 11, 2013 /PRNewswire/ -- Abbott (NYSE: ABT) today announced positive long-term results for the company's innovative Absorb(TM) Bioresorbable Vascular Scaffold (BVS). Three-year results from 101 patients in the second stage of the ABSORB trial were presented at the 62nd Annual Scientific Session of the American College of...

- Study Found that Cardiologists Changed Their Diagnostic Testing Strategy in 60 Percent of Female Patients Following Corus CAD Testing - PALO ALTO, Calif., March 11, 2013 /PRNewswire/ -- CardioDx, Inc., a pioneer in the field of cardiovascular genomic diagnostics, today announced results of a prospective study that evaluated how Corus(®) CAD, a blood-based gene expression test, influenced cardiologists' patient management decisions in women with suspected obstructive coronary...

Exposure to tobacco smoke may be more dangerous than previously thought, research says Nonsmokers, beware. It seems the more you are exposed to secondhand tobacco smoke—whether it was during your childhood or as an adult, at work or at home—the more likely you are to develop early signs of heart disease, according to research being presented at the American College of Cardiology's 62nd Annual Scientific Session. Researchers found that 26 percent of people exposed to varying levels...

Scottsdale Healthcare is first in region to implant investigational device in patients with clogged arteries SCOTTSDALE, Ariz., March 4, 2013 /PRNewswire-USNewswire/ -- A dissolvable stent that opens clogged arteries in the heart has researchers at Scottsdale Healthcare encouraged that it may become a game changing technology for treating the symptoms of coronary artery disease (CAD), the most common type of heart disease. Interventional cardiologist David Rizik, MD is the first...

PALO ALTO, Calif., March 4, 2013 /PRNewswire/ -- CardioDx, Inc., a pioneer in the field of cardiovascular genomic diagnostics, announced that clinical data from studies of Corus® CAD, the only clinically validated gene expression test for obstructive coronary artery disease (CAD), will be presented at the American College of Cardiology 62(nd) Annual Scientific Session taking place March 9-11, 2013 at the Moscone Center in San Francisco, CA. (Logo:...

Chief Medical Officer Dr. Howard Walpole, Jr. discusses healthcare readmission reduction at the 13th Annual American College of Cardiology’s World Conference, March 10. FREEPORT, The Bahamas (PRWEB) February 28, 2013 Okyanos Heart Institute, which brings a new standard of care and better quality of life to patients with chronic coronary artery disease using cardiac stem cell therapy, announces that Chief Medical Officer Howard Walpole Jr., M.D., MBA, FACC, FACAI will speak at The...

CARLSBAD, Calif., Feb. 26, 2013 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced the initiation of a Phase 2 study evaluating ISIS-CRP(Rx) in patients with paroxysmal atrial fibrillation. Atrial fibrillation (AF) involves an irregular and often rapid heart rate that commonly causes poor blood flow to the body. Paroxysmal AF is a type of AF characterized by unpredictable episodes of AF that can occur as frequently as every day. Patients with AF can experience chest...

PALO ALTO, Calif., Feb. 25, 2013 /PRNewswire/ -- CardioDx, Inc., a pioneer in the field of cardiovascular genomic diagnostics, today announced that the company will present at the Cowen and Company 33(rd) Annual Healthcare Conference on Monday, March 4, 2013 at 10:00 a.m. ET at the Boston Marriott Copley Place in Boston. Andrew Guggenhime, the company's Chief Financial Officer, will provide an overview of CardioDx and Corus® CAD, the only clinically validated gene expression test...

Chief Medical Officer Dr. Howard T. Walpole, Jr. To Speak To Cardiovascular Leaders On Running A Cardiovascular Practice In Today’s Healthcare Environment Freeport, The Bahamas (PRWEB) February 21, 2013 Okyanos Heart Institute, which brings a new standard of care and better quality of life to patients with chronic coronary artery disease using cardiac stem cell therapy, announces that Chief Medical Officer Howard T. Walpole Jr., M.D., MBA, FACC, FACAI will speak at The American College...